一种酸结合的端粒酶依赖的端粒向核酸体证明结肠直肠癌直接杀死和免疫信号
Merve Yilmaz1,2, Sibel Goksen3, Ilgen Mender4
1Department of Medical Biochemistry, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.
Biomolecules
|January 8, 2025
概括
一种针对端粒的新型前体药物 - - 迪赫萨诺伊尔-酸-THIO (diC6-THIO) 通过修改端粒和激活免疫细胞,显示出强大的抗癌活性. 这种双重作用增强了其作为癌症治疗有前途的治疗候选者的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 端粒酶和端粒对于癌细胞生存至关重要,是癌症治疗的关键标.
- 目前的治疗方法,如6-thio-dG (THIO) 与抗PD-1 抑制剂相结合,正在针对耐药癌症进行研究.
- 需要新的策略来提高癌症治疗的疗效和克服抗药性.
研究的目的:
- 设计,合成和评估针对端粒的新型双模块结合分子.
- 为了评估dihexanoyl-phosphatidyl-THIO (diC6-THIO) 的抗癌活性和作用机制.
- 在癌症模型中研究diC6-THIO的免疫调节作用和治疗潜力.
主要方法:
- 新型针对端粒的核酸类模拟合物的合成和体外评估.
- 在各种癌症细胞系和小鼠结直肠癌模型中评估抗癌活性.
- 通过端粒功能障碍的端粒修饰的分析 诱导焦点 (TIFs) 的形成和免疫细胞概况 (CD4 +,CD8 +,调节性T细胞).
主要成果:
- 在体外,dihexanoyl-phosphatidyl-THIO (diC6-THIO) 具有强大的抗癌活性,EC50值低于μM.
- 在体内研究表明,单独使用diC6-THIO和与PD1/PD-L1抑制剂一起在小鼠模型中具有强烈的抗癌作用.
- 该化合物诱导了TIFs,证实了端粒修饰,并增强了CD4+/CD8+ T细胞反应,同时减少了调节性T细胞.
结论:
- 迪赫萨诺伊尔-酸-THIO (diC6-THIO) 是一种具有双重作用机制的有前途的端粒向前药.
- 它有效地修改端粒并激活免疫系统,提供了一种新的治疗策略.
- 提高溶解度和强大的抗癌性质支持其作为进一步临床开发候选人的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:41Telomeres and Telomerase
23.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.0K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K